moxisylyte has been researched along with cardiovascular agents in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooke, ED; Nicolaides, AN | 1 |
1 review(s) available for moxisylyte and cardiovascular agents
| Article | Year |
|---|---|
Raynaud's syndrome.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Epoprostenol; Female; Humans; Iloprost; Moxisylyte; Nifedipine; Raynaud Disease | 1990 |